
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Relmadas experienced and dedicated team is committed to making a difference in the lives of patients and their families. Relmadas lead program, REL-1017, is a new chemical entity (NCE) and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 has entered late-stage development as an adjunctive treatment and monotherapy for MDD in adults. In addition, Relmada is advancing a clinical-stage program in neurodegenerative diseases based on psilocybin and select...
Analgesic drug development,chronic pain,pharmaceutical development,and opioid addiction
Relmada therapeutics, inc operates in the Pharmaceutical manufacturing industry.
Relmada therapeutics, inc's HQ phone number is +1 570-708-8780
Relmada therapeutics, inc's revenue is 11m - 100m
Relmada therapeutics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.